88. Gaydos, L.A., E.J. Freireich, and N.
Mantel, The quantitative relation between platelet count and hemorrhage in
patients with acute leukemia.
N Engl J Med, 1962. 266: p. 905-9. PMID:
13897369.
https://pubmed.ncbi.nlm.nih.gov/13897369/
90. Slichter, S.J. and L.A. Harker,
Thrombocytopenia: mechanisms and management of defects in platelet production.
Clin Haematol,
1978. 7(3): p. 523-39. PMID: 363326.
https://pubmed.ncbi.nlm.nih.gov/363326/
94. Gmur, J., et al., Safety of stringent
prophylactic platelet transfusion policy for patients with acute leukaemia.
Lancet, 1991. 338(8777): p. 1223-6. PMID:
1682642.
https://pubmed.ncbi.nlm.nih.gov/1682642/
118. Heal, J.M., et al., The role of
ABO matching in platelet transfusion.
Eur J Haematol, 1993. 50(2): p. 110-7. PMID:
8440356.
https://pubmed.ncbi.nlm.nih.gov/8440356/
120.
Carr, R., et al., Transfusion of
ABO-mismatched platelets leads to early platelet refractoriness.
Br J Haematol,
1990. 75(3): p. 408-13. PMID: 2201403.
https://pubmed.ncbi.nlm.nih.gov/2201403/
132. Yankee, R.A., F.C. Grumet, and
G.N. Rogentine, Platelet transfusion The selection of compatible platelet donors for refractory
patients by lymphocyte HL-A typing.
N Engl J Med, 1969. 281(22): p. 1208-12.
PMID: 5347838.
https://pubmed.ncbi.nlm.nih.gov/5347838/
134.
Claas, F.H., et al., Alloimmunization against the MHC antigens after
platelet transfusions is due to contaminating leukocytes in the platelet
suspension.
Exp Hematol, 1981.
9(1): p. 84-9. PMID: 7238645.